UroGen Pharma, Inc.

We are a biopharmaceutical company dedicated to building novel solutions that treat urothelial and specialty cancers. Our breakthrough therapy and innovative clinical pipeline aim to maximize the potential benefit of local delivery with our novel RTGel technology by bringing to patients transformative, nonsurgical approaches to challenging urothelial and specialty cancers—because we believe patients deserve better.